ClinConnect ClinConnect Logo
Search / Trial NCT07126600

Data Collection for Echocardiography-Based Software Assessment

Launched by ANUMANA, INC. · Aug 10, 2025

Trial Information

Current as of September 07, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical study is looking at how well a new computer program works by using information gathered during regular heart procedures. Specifically, it focuses on patients who are having a common treatment called left atrial appendage closure, which helps reduce the risk of stroke in people with an irregular heartbeat known as atrial fibrillation. The study does not involve any new treatments or extra tests—only data from usual care is collected.

If you are between 65 and 74 years old and are scheduled for this standard heart procedure, you might be eligible to participate. To join, you simply need to agree to let researchers use your medical information, which is kept private and secure. Being part of the study won’t change your treatment or add any extra steps; it just helps doctors understand if the new software can assist in analyzing heart images better in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Undergoing a standard left atrial appendage closure procedure with associated imaging.
  • Exclusion Criteria:
  • Did not provide authorization to use data for research purposes.

About Anumana, Inc.

Anumana, Inc. is an innovative biotechnology company dedicated to advancing cardiovascular care through the integration of artificial intelligence and machine learning with clinical diagnostics. By harnessing the power of data analytics, Anumana aims to enhance the accuracy and efficiency of cardiovascular disease detection and management. The company is committed to developing cutting-edge solutions that facilitate early intervention and personalized treatment pathways, ultimately improving patient outcomes and transforming the landscape of cardiac health. With a focus on rigorous clinical trials and collaborations with leading healthcare institutions, Anumana is at the forefront of redefining the future of cardiovascular medicine.

Locations

Boston, Massachusetts, United States

Boston, Massachusetts, United States

Worcester, Massachusetts, United States

New Bedford, Massachusetts, United States

Amherst, New York, United States

Patients applied

0 patients applied

Trial Officials

Leon Ptaszek, MD, PhD

Principal Investigator

Massachusetts General Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported